Good post.
Re your point 2, yes one would think that other cardioprotective (although not synergistic) drugs have already been through this phase, and we could copy their methods.
I'm not happy with important preclinical results, whether good or bad, being withheld until a quarterly.
- Forums
- ASX - By Stock
- RAC
- Ann: Quarterly Activity Report & Appendix 4C
Ann: Quarterly Activity Report & Appendix 4C, page-60
-
-
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.85 |
Change
-0.090(4.64%) |
Mkt cap ! $315.1M |
Open | High | Low | Value | Volume |
$1.93 | $1.97 | $1.85 | $314.6K | 164.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 44 | $1.85 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.89 | 500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 44 | 1.850 |
2 | 8804 | 1.840 |
3 | 6774 | 1.830 |
1 | 100 | 1.820 |
6 | 12943 | 1.800 |
Price($) | Vol. | No. |
---|---|---|
1.890 | 500 | 1 |
1.910 | 2941 | 1 |
1.940 | 148 | 1 |
1.950 | 1000 | 1 |
1.975 | 2000 | 1 |
Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |